Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation
Status:
Not yet recruiting
Trial end date:
2024-01-10
Target enrollment:
Participant gender:
Summary
The therapeutic effect of nebulized salbutamol on hyperkalemia during reperfusion in liver
transplantation patients. Secondary research objectives: To observe the results of blood gas
analysis, changes in urinary potassium and hemodynamic parameters, and the incidence of
reperfusion syndrome in liver transplantation, and to observe the incidence of postoperative
pulmonary complications during the 7-day follow-up. To explore the effect of aerosol
inhalation of salbutamol on new liver reperfusion syndrome in patients with liver
transplantation, and to provide a theoretical basis for clinical treatment.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University